Prescribing for older adults

Beauchamp TL Childress JF (2013) Principles of Biomedical Ethics, 7th edn. Oxford: Oxford University Press.

Blenkinsopp A Bond C Raynor DK (2012) Medication reviews. British Journal of Clinical Pharmacology 74(4): 573–580. DOI: 10.1111/j.1365-2125.2012.04331.x.

British Geriatrics Society (2024) Older adult pharmacy resources. Available at: www.bgs.org.uk/older-adult-pharmacy-resources (accessed 8 March 2026).

British Geriatrics Society (2025) Pragmatic Prescribing to Reduce Harm for Older People with Moderate to Severe Frailty. Available at: www.bgs.org.uk/PragmaticPrescribing (accessed 21 May 2026)..

CGAKit (2023) STOPP-START v.3: Screening tool of older people’s prescriptions and screening tool to alert to right treatment. Available at: www.cgakit.com/stopp-start-v3 (accessed 8 March 2026).

Gallagher PF O’Connor MN O’Mahony D (2011) Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clinical Pharmacology & Therapeutics 89(6): 845–854. DOI: 10.1038/clpt.2011.44.

Guthrie B Makubate B Hernandez-Santiago V , et al. (2015) The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995–2010. BMC Medicine 13: 74. DOI: 10.1186/s12916-015-0322-7.

Hilmer SN McLachlan AJ Le Couteur DG (2007) Clinical pharmacology in the geriatric patient. Fundamental & Clinical Pharmacology 21(3): 217–230. DOI: 10.1111/j.1472-8206.2007.00473.x.

Mangoni AA Jackson SHD (2004) Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. British Journal of Clinical Pharmacology 57(1): 6–14. DOI: 10.1046/j.1365-2125.2003.02007.x.

Milton JC Hill-Smith I Jackson SHD (2008) Prescribing for older people. BMJ 336(7644): 606–609. DOI: 10.1136/bmj.39503.424653.80.

NICE (2022a) Chronic kidney disease: assessment and management (NG203). Available at: www.nice.org.uk/guidance/ng203 (accessed 16 May 2026).

NICE (2015) Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes (NG5). Available at: www.nice.org.uk/guidance/ng5 (accessed 16 May 2026).

NICE (2022b) Multimorbidity and polypharmacy. Available at: NICE website (Accessed: 16 May 2026).

NHS Business Services Authority (2024) Prescription Cost Analysis – England 2023/24. Available at: www.nhsbsa.nhs.uk/statistical-collections/prescription-cost-analysis-england/prescription-cost-analysis-england-202324 (Accessed: 16 May 2026).

NHS Confederation (2023) Taking stock: the experience of medicines optimisation in integrated care systems. Available at: www.nhsconfed.org/system/files/2023-06/Taking-stock-experience-of-medicines-optimisation-in-ICSs%20%281%29.pdf (accessed 8 March 2026).

NHS England (n.d.) Improving care for older people. Available at: www.england.nhs.uk/ourwork/clinical-policy/older-people/improving-care-for-older-people/ (accessed 8 March 2026).

Office for National Statistics (2021) Profile of the older population living in England and Wales in 2021 and changes since 2011. Available at: www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/ageing/articles/profileoftheolderpopulationlivinginenglandandwalesin2021andchangessince2011/2023-04-03 (Accessed: 16 May 2026).

O’Mahony D. O’Sullivan D. Byrne S. O’Connor M.N. Ryan C. Gallagher P. (2015) STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age and Ageing, 44(2): 213–218. DOI: 10.1093/ageing/afu145.

Pirmohamed M James S Meakin S , et al. (2004) Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 329(7456): 15–19. DOI: 10.1136/bmj.329.7456.15.

Reeve E Gnjidic D Long J , et al. (2015) A systematic review of the emerging definition of ‘deprescribing’ with network analysis: implications for future research and clinical practice. British Journal of Clinical Pharmacology 80(6): 1254–1268. DOI: 10.1111/bcp.12732.

Royal Pharmaceutical Society (2013) Medicines Optimisation: Helping Patients to Make the Most of Medicines. London: Royal Pharmaceutical Society.

Schlenk EA Dunbar-Jacob J Engberg S (2004) Medication non-adherence among older adults: a review of strategies and interventions for improvement. Journal of Gerontological Nursing 30(7): 33–43.

Scott IA Hilmer SN Reeve E , et al. (2015) Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Internal Medicine 175(5): 827–834. DOI: 10.1001/jamainternmed.2015.0324.

Scottish Medicines Consortium (2021) A guide to anticholinergic burden tools (including the Anticholinergic Burden Calculator). Glasgow: NHS Scotland. Available at: www.scottishmedicines.org.uk (accessed: 16 May 2026).

Turnheim K (1998) Drug dosage in the elderly. Is it rational? Drugs & Aging 13(5): 357–379. DOI: 10.2165/00002512‑199813050‑00003.

Zazzara M.B. Palmer K. Vetrano D.L. Carfì A. Onder G. (2021) Adverse drug reactions in older adults: a narrative review of the literature. European Geriatric Medicine, 12(3): . 455–476. DOI: 10.1007/s41999-021-00481-9.